These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 16040625

  • 1. Tigecycline.
    Pankey GA.
    J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
    [Abstract] [Full Text] [Related]

  • 2. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE, Rybak MJ.
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [Abstract] [Full Text] [Related]

  • 3. Tigecycline: a new glycylcycline for treatment of serious infections.
    Noskin GA.
    Clin Infect Dis; 2005 Sep 01; 41 Suppl 5():S303-14. PubMed ID: 16080069
    [Abstract] [Full Text] [Related]

  • 4. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW, Neumiller JJ, Setter SM.
    Clin Ther; 2005 Jan 01; 27(1):12-22. PubMed ID: 15763603
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul 01; 52(3):187-93. PubMed ID: 16105563
    [Abstract] [Full Text] [Related]

  • 6. In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002.
    Bouchillon SK, Hoban DJ, Johnson BM, Stevens TM, Dowzicky MJ, Wu DH, Bradford PA.
    Diagn Microbiol Infect Dis; 2005 Apr 01; 51(4):291-5. PubMed ID: 15808321
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).
    Hoban DJ, Bouchillon SK, Johnson BM, Johnson JL, Dowzicky MJ, Tigecycline Evaluation and Surveillance Trial (TEST Program) Group.
    Diagn Microbiol Infect Dis; 2005 Jul 01; 52(3):215-27. PubMed ID: 16105567
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK, Hoban DJ, Johnson BM, Johnson JL, Hsiung A, Dowzicky MJ, Tigecycline Evaluation and Surveillance Trial (TEST) Group.
    Diagn Microbiol Infect Dis; 2005 Jul 01; 52(3):173-9. PubMed ID: 16105561
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS, Jones RN, Dowzicky MJ, Fritsche TR.
    Diagn Microbiol Infect Dis; 2005 Jul 01; 52(3):203-8. PubMed ID: 16105565
    [Abstract] [Full Text] [Related]

  • 10. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP.
    J Infect; 2006 Nov 01; 53(5):293-300. PubMed ID: 16876253
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007.
    Garrison MW, Mutters R, Dowzicky MJ.
    Diagn Microbiol Infect Dis; 2009 Nov 01; 65(3):288-99. PubMed ID: 19733459
    [Abstract] [Full Text] [Related]

  • 12. Tigecycline: a novel glycylcycline antibiotic.
    Zhanel GG, Karlowsky JA, Rubinstein E, Hoban DJ.
    Expert Rev Anti Infect Ther; 2006 Feb 01; 4(1):9-25. PubMed ID: 16441206
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N, Marchandin H, Dowzicky MJ.
    Int J Antimicrob Agents; 2009 Aug 01; 34(2):121-30. PubMed ID: 19342205
    [Abstract] [Full Text] [Related]

  • 14. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
    Fernández Canigia L, Kaufman S, Lanata L, Vay C, Giovanakis M, Bantar C, Argentinean Tigecycline Surveillance Group.
    Chemotherapy; 2009 Aug 01; 55(1):20-7. PubMed ID: 18974645
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
    Bouchillon SK, Iredell JR, Barkham T, Lee K, Dowzicky MJ.
    Int J Antimicrob Agents; 2009 Feb 01; 33(2):130-6. PubMed ID: 18995992
    [Abstract] [Full Text] [Related]

  • 16. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
    Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul 01; 52(3):195-201. PubMed ID: 16105564
    [Abstract] [Full Text] [Related]

  • 17. Tigecycline: in-vitro performance as a predictor of clinical efficacy.
    Hawkey P, Finch R.
    Clin Microbiol Infect; 2007 Apr 01; 13(4):354-62. PubMed ID: 17359318
    [Abstract] [Full Text] [Related]

  • 18. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
    Roveta S, Marchese A, Debbia EA.
    Chemotherapy; 2008 Apr 01; 54(1):43-9. PubMed ID: 18073470
    [Abstract] [Full Text] [Related]

  • 19. Tigecycline: clinical evidence and formulary positioning.
    Nathwani D.
    Int J Antimicrob Agents; 2005 Mar 01; 25(3):185-92. PubMed ID: 15737510
    [Abstract] [Full Text] [Related]

  • 20. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
    Sader HS, Jones RN, Stilwell MG, Dowzicky MJ, Fritsche TR.
    Diagn Microbiol Infect Dis; 2005 Jul 01; 52(3):181-6. PubMed ID: 16105562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.